Vaccitech

IPO

Guiding the immune system to cure disease

Vaccitech was founded in 2016, is headquartered in Oxford, United Kingdom, lists 51–200 employees, and has $206.4M in recorded funding across 3 rounds.

Headquarters
Oxford
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$206.4M
Last Round
$168.0M Series BMar 2021
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Its pipeline is built around four proprietary platform technologies, ChAdOx, MVA, SNAP-TI, and SNAP-CI, and advances five product candidates including VTP-300 for chronic HBV infection, VTP-1000 for celiac disease, and VTP-850 for recurrent prostate cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics.

Summary

Vaccitech is a Biotech company based in Oxford, United Kingdom, founded in 2016. It lists 51–200 employees. It has raised $206.4M in total across 3 rounds, most recently a $168.0M Series B round in Mar 2021. Investors include M&G Investments, GV and Sequoia China.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOMay 2021
$110.5M

Sign up to see all 4 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vaccitech on Indexed.vc
<a href="https://indexed.vc/companies/vaccitech"><img src="https://indexed.vc/api/badge/company/vaccitech" alt="Vaccitech on Indexed.vc" width="260" height="76" /></a>